(firstQuint)The Evaluation of Safety, Tolerability, and Pharmacokinetics for Fruquintinib in Solid Tumors.

 The study is an open-label, dose escalation clinical trial to evaluate the safety, tolerability, and PK of fruquintinib in patients with advanced solid tumors.

 Study will be conducted in up to 5 sites in the US.

.

 The Evaluation of Safety, Tolerability, and Pharmacokinetics for Fruquintinib in Solid Tumors@highlight

An open-label, dose escalation clinical trial to evaluate the safety, tolerability, and PK of fruquintinib in patients with advanced solid tumors.

